To investigate the therapeutic mechanisms of a Risdiplam-like compound in a three-dimensional stem cell-derived spinal cord model for Spinal Muscular Atrophy (SMA) and assess its efficacy in reversing the disease's pathological hallmarks.
No takes yet. Share an insight, caveat, or question.
D’Angelo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: